USD
+$0.00
(+0.00%
)At Close (As of Oct 14, 2025)
$36.53M
Market Cap
-
P/E Ratio
-3.56
EPS
$7.13
52 Week High
$3.33
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | $654K |
Total Revenue | $1.3M |
Cost Of Revenue | $682K |
Costof Goods And Services Sold | $682K |
Operating Income | -$23M |
Selling General And Administrative | $10M |
Research And Development | $14M |
Operating Expenses | $24M |
Investment Income Net | - |
Net Interest Income | $271K |
Interest Income | $1.1M |
Interest Expense | $873K |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | - |
Income Before Tax | -$23M |
Income Tax Expense | - |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$23M |
Comprehensive Income Net Of Tax | - |
Ebit | - |
Ebitda | -$23M |
Net Income | -$23M |
Field | Value (USD) |
---|---|
Total Assets | $17M |
Total Current Assets | $22M |
Cash And Cash Equivalents At Carrying Value | $5.9M |
Cash And Short Term Investments | $5.9M |
Inventory | - |
Current Net Receivables | $424K |
Total Non Current Assets | -$5.5M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | $2.8M |
Intangible Assets Excluding Goodwill | $2.8M |
Goodwill | $3.1M |
Investments | - |
Long Term Investments | - |
Short Term Investments | $15M |
Other Current Assets | $16M |
Other Non Current Assets | - |
Total Liabilities | $7.2M |
Total Current Liabilities | $32M |
Current Accounts Payable | $1.3M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $659K |
Total Non Current Liabilities | $6.5M |
Capital Lease Obligations | $6.8M |
Long Term Debt | - |
Current Long Term Debt | $27M |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $6.8M |
Other Current Liabilities | $30M |
Other Non Current Liabilities | - |
Total Shareholder Equity | -$6.8M |
Treasury Stock | - |
Retained Earnings | -$443M |
Common Stock | - |
Common Stock Shares Outstanding | $63M |
Field | Value (USD) |
---|---|
Operating Cashflow | -$18M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $316K |
Capital Expenditures | $1.6M |
Change In Receivables | - |
Change In Inventory | - |
Profit Loss | - |
Cashflow From Investment | $8M |
Cashflow From Financing | $9.5M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | - |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$23M |
Field | Value (USD) |
---|---|
Gross Profit | $654K |
Total Revenue | $1.3M |
Cost Of Revenue | $682K |
Costof Goods And Services Sold | $682K |
Operating Income | -$23M |
Selling General And Administrative | $10M |
Research And Development | $14M |
Operating Expenses | $24M |
Investment Income Net | - |
Net Interest Income | $271K |
Interest Income | $1.1M |
Interest Expense | $873K |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | - |
Income Before Tax | -$23M |
Income Tax Expense | - |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$23M |
Comprehensive Income Net Of Tax | - |
Ebit | - |
Ebitda | -$23M |
Net Income | -$23M |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
None